Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

Share Price is delayed by 15 minutes
Get Live Data
4,430.00    -16.00 (-0.36%)
Bid:
4,410.00
Ask:
4,414.00
Spread: 4.00 (0.091%)
Market Cap: £2.07b
MGNS Live PriceLast checked at - London Stock Exchange

Intraday Morgan Sindall Group Share Chart

Directorate Change

14 Aug 2018 07:00

RNS Number : 6648X
Morgan Sindall Group PLC
14 August 2018
 
Morgan Sindall Group plc

 

14 August 2018

 

Morgan Sindall appoints David Lowden as a non-executive director

 

Morgan Sindall Group plc is pleased to announce the appointment of David Lowden as a non-executive director, with effect from 10 September 2018. David will be a member of the remuneration, nomination and audit committees.

 

David is a highly experienced Non-executive Director, Senior Independent Director and Chairman of UK listed companies. David is currently chair of the Board of FTSE 250 PageGroup having previously chaired the Remuneration Committee for three years. He is also chair of the audit & risk committee at William Hill and recently stepped down as SID from the Board of Berendsen. David was formerly Chief Executive of Taylor Nelson Sofres plc, having initially joined as Group Finance Director in 1999. David has spent his career working for a number of companies in senior finance roles, including as Group Finance Director at Asprey plc prior to joining Taylor Nelson Sofres. As a CFO as well as CEO, he has supported growth and profitability through the efficient design of business operations and appropriate use of systems and processes.

 

Commenting on the appointment, Michael Findlay, chairman of Morgan Sindall Group plc, said:

 

"We are delighted to welcome David to the Board. His extensive experience as both an executive and non-executive director of various successful companies will bring valuable knowledge and insight to Board discussions. I look forward to working with David in the coming years."

 

Ends

Notes to Editors:

There are no other details requiring disclosure under Listing Rule 9.6.13 in relation to David Lowden.

 

Morgan Sindall Group plc is a leading UK construction and regeneration group with revenue of c£2.8 billion and which operates through six divisions of Construction & Infrastructure, Fit Out, Property Services, Partnership Housing, Urban Regeneration and Investments.

 

ENQUIRIES:

Morgan Sindall Group plc

Tel: 07816 958187

Michael Findlay, Chair

Instinctif Partners (Financial PR)

Tel: 020 7457 2020

MorganSindall@instinctif.com

 

Matthew Smallwood

 

Tel: 07831 379 122

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOABLGDICGBBGIX
Date   Source Headline
3rd Jun 202611:56 amRNSDirector/PDMR Shareholding
1st Jun 20269:27 amRNSTotal Voting Rights
27th May 20261:29 pmRNSAdmission to Trading
20th May 202611:35 amRNSIssue of Equity
7th May 202612:38 pmRNSResult of AGM
1st May 20261:33 pmRNSDirector/PDMR Shareholding
1st May 202610:57 amRNSTotal Voting Rights
20th Apr 20263:44 pmRNSHolding(s) in Company
16th Apr 20264:09 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSTrading and Outlook for 2026
14th Apr 20262:18 pmRNSAdmission to Trading
1st Apr 20269:53 amRNSTotal Voting Rights
26th Mar 20261:27 pmRNSHolding(s) in Company
24th Mar 202612:56 pmRNSAnnual Financial Report
20th Mar 202612:42 pmRNSIssue of Equity
9th Mar 20263:35 pmRNSDirector/PDMR Shareholding
9th Mar 20263:35 pmRNSDirector/PDMR Shareholding
9th Mar 20263:30 pmRNSDirector/PDMR Shareholding
9th Mar 20263:30 pmRNSDirector/PDMR Shareholding
4th Mar 20262:38 pmRNSDirector/PDMR Shareholding
4th Mar 20262:36 pmRNSDirector/PDMR Shareholding
3rd Mar 20263:33 pmRNSIssue of Equity / Admission to Trading
2nd Mar 20269:22 amRNSTotal Voting Rights
26th Feb 20269:53 amRNSDirector Declaration
25th Feb 20267:00 amRNSResults for the Full Year ended 31 December 2025
12th Feb 20267:00 amRNSTrading and Outlook for 2026
2nd Feb 20269:13 amRNSTotal Voting Rights
19th Jan 20267:00 amRNSNotice of Full Year Results
2nd Jan 202611:09 amRNSTotal Voting Rights
16th Dec 202510:16 amRNSAdditional Listing
2nd Dec 20259:12 amRNSTotal Voting Rights
25th Nov 20254:14 pmRNSHolding(s) in Company
12th Nov 20254:07 pmRNSDirector/PDMR Shareholding
3rd Nov 202510:58 amRNSTotal Voting Rights
20th Oct 202511:24 amRNSBlock listing Interim Review
20th Oct 20259:32 amRNSDirector/PDMR Shareholding
2nd Oct 20257:00 amRNSTrading Update and Outlook for 2025
1st Oct 20259:05 amRNSTotal Voting Rights
1st Sep 20258:59 amRNSTotal Voting Rights
4th Aug 20253:09 pmRNSDirector/PDMR Shareholding
1st Aug 20257:00 amRNSTotal Voting Rights
29th Jul 20257:00 amRNSResults For the Half Year (HY) Ended 30 June 2025
18th Jul 20258:40 amRNSHolding(s) in Company
1st Jul 20259:34 amRNSTotal Voting Rights
25th Jun 20258:47 amRNSAdditional Listing
24th Jun 20257:00 amRNSNotice of Half Year Results
17th Jun 20257:00 amRNSTrading Update and Outlook for 2025
16th Jun 20251:55 pmRNSDirector/PDMR Shareholding
2nd Jun 20253:45 pmRNSTotal Voting Rights
2nd Jun 202511:14 amRNSCompany Secretary Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.